RevOpsis Welcomes Dr. Emmett Cunningham to Strategic Advisory Board
/PRNewswire/ -- RevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today the...
Source: prnewswire.com
Emmett Cunningham News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Emmett Cunningham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Emmett Cunningham Today - Breaking & Trending Today
New ophthalmology company hits the market
"Ascendis Pharma partners with Frazier Life Sciences, RA Capital Management, venBio, and HealthQuest Capital to launch ophthalmology company Eyconis. Eyconis wi
Source: beckersasc.com
New Company Eyconis Formed to Develop Ascendis Pharma Ophthalmology Assets with $150 Million ...
COPENHAGEN, Denmark, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced the formation and launch with Frazier Life Sciences of Eyconis, Inc., a separate company created
Source: eagletribune.com
Lumos Pharma Announces Changes to its Board of Directors
Share: AUSTIN, Texas, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced the appointment of An van Es-Johansson, M.D., to its Board of Directors, effective immediately, where she will serve as a member of the Nominating and Governance Committee. Dr. van Es-Johansson brings over 30 years of experience in executive and clinical development roles in the pharmaceutical industry. Dr. van Es-Johansson will succeed Emmett Cunningham who is resigning his Board position to focus on other ...
Source: benzinga.com